Diana N. Vaz Saleiro, Ph.D.

Affiliations: 
2013 Biology Illinois Institute of Technology, Chicago, IL, United States 
Area:
Oncology, Molecular Biology
Google:
"Diana Saleiro"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Rajendra G. Mehta grad student 2013 Illinois Institute of Technology
 (Molecular mechanisms of estrogen receptor beta action in colorectal carcinogenesis.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kosciuczuk EM, Kar AK, Blyth GT, et al. (2019) Inhibitory effects of SEL201 in acute myeloid leukemia. Oncotarget. 10: 7112-7121
Saleiro D, Platanias LC. (2019) Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints. Seminars in Immunology. 43: 101299
Kosciuczuk EM, Mehrotra S, Saleiro D, et al. (2018) Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses. The Journal of Biological Chemistry
Saleiro D, Blyth GT, Kosciuczuk EM, et al. (2018) IFN-γ-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5. Science Signaling. 11
Fischietti M, Arslan AD, Sassano A, et al. (2018) Slfn2 Regulates Type I Interferon Responses by Modulating the NFĸB Pathway. Molecular and Cellular Biology
Arslan AD, Sassano A, Saleiro D, et al. (2017) Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma. Oncogene. 36: 6006-6019
Kroczynska B, Blyth GT, Rafidi RL, et al. (2017) Central Regulatory Role for SIN1 in Interferon γ (IFNγ) Signaling and Generation of Biological Responses. The Journal of Biological Chemistry
Saleiro D, Radecki SG, Platanias LC. (2016) Mesenchymal stromal cells and Interferon α (IFNα) in cancer immunotherapy. Translational Cancer Research. 5: S1039-S1043
Kosciuczuk EM, Saleiro D, Kroczynska B, et al. (2016) Merestinib blocks MNK kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo. Blood
Kosciuczuk EM, Saleiro D, Platanias LC. (2016) Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia. Cytokine
See more...